Atlas Trials

A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

Clinical trial NCT03442764 · COMPLETED

Trial details

NCT number
NCT03442764
Sponsor
MyoKardia, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-obstructive Hypertrophic Cardiomyopathy
Start date
2018-03-30
Primary completion
2020-01-07
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.